The Rotterdam Asthma Trial
- Conditions
- Asthma in children
- Registration Number
- NL-OMON20109
- Lead Sponsor
- Erasmus Medical Center Rotterdam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 180
Inclusion Criteria
Patients who were prescribed one or more times an ICS in the last year.
-Patients who were prescribed 2 or more times a prescription of salbutamol or terbutaline in the last year.
Exclusion Criteria
-Children receiving asthma treatment from secondary care.
-Children who are not able to perform lung function tests.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study parameter is the overall asthma control in 18 months measured by the Childhood Asthma Control Test (C-ACT)
- Secondary Outcome Measures
Name Time Method 1. C-ACT outcomes during follow-up at 3, 6, 12 and 18 months. <br /><br>2. Frequency and severity of exacerbations<br /><br>3. Cost-effectiveness <br /><br>4. Quality of life assessed by the Standardised Paediatric Asthma Quality of Life Questionnaire (PAQLQ(S))<br /><br>5. Patient/parent/nurse/GP satisfaction with delivered care<br /><br>6. Spirometry: FEV1, Forced Expiratory Flow 75 (FEF 75) and reversibility